March 28, 2025 — Novartis has announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with an

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a prospective study in Nature Communications validating the real-world effectiveness of AI-powered mammography screening in South Korea’s national breast cancer screening program

March 4, 2025 — At HIMSS 2025 in Las Vegas, GE HealthCare announced Genesis solutions — a new portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will be offered when commercially released — edge, storage, vendor neutral archive and data migration.[i] These

March 3, 2025 — Microsoft Corp. has unveiled Microsoft Dragon Copilot, an AI assistant for clinical workflow that brings together the trusted natural language voice dictation capabilities of DMO with the ambient listening capabilities of DAX, fine-tuned generative AI and healthcare-adapted

Feb. 21, 2025 — Royal Philips and Mass General Brigham (MGB), have announced a new collaboration to develop and deploy advanced data infrastructure and AI designed to integrate and process live healthcare data from a wide range of sources to improve patient care. Today, healthcare providers often